The PI3K/mTOR inhibitor GSK2126458 is effective for treating TSC solid renal tumours
Sunday, May 28, 2017 - 13:32
in Health & Medicine
Tuberous sclerosis (TSC) is an inherited tumour syndrome that shares clinical similarities with Birt-Hogg-Dube Syndrome. It is caused by mutations in TSC1 or TSC2 that lead to aberrant activation of mTOR, affecting multiple organs, including the kidney and lung. ... Read more